As of 2026-06-24, the GLP-1 Drugs (Ozempic®, Mounjaro® and Alternatives) is open. You can check whether you qualify with the free 1-minute eligibility self-check below.
| Case | GLP-1 Drugs (Ozempic®, Mounjaro® and Alternatives) |
|---|---|
| Status | Open |
| Law firm | Siskinds LLP |
| Jurisdiction | Canada |
| Filing deadline | See case details |
Last verified: 2026-06-24
Glucagon-like peptide-1 receptor agonists (aka GLP-1 drugs) are pharmaceutical drugs that have been approved by regulators as treatments for type 2 diabetes and – in some cases – for chronic weight management. These medications work by mimicking the GLP-1 hormone, which helps regulate blood sugar le
Check if you qualify →← Browse all 3196+ class actions
This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.